Uipath is trading 4.1% down at $14.56 as investors continue reassessing its September 3 earnings despite raised full-year guidance.

  • Reports highlighted softer forward growth expectations, with third-quarter guidance implying approximately 8% growth, alongside slower enterprise decision-making and concerns about AI competition.
  • The September 8 decline appears company-specific rather than broad-market driven: major indexes were only modestly lower, while Uipath followed sharp September 4 earnings-related drop.
  • Management’s Citi conference appearance is scheduled for later on September 8.